Creative Planning raised its holdings in shares of Iovance Biotherapeutics by 2.6% in the 3rd quarter. Creative Planning now owns 73,489 shares of the biotechnology company’s stock worth $ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
